Back
United Therapeutics Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
UTHR
United Therapeutics
Last Price:
$292.42
Seasonality Move:
4.96%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing selling pressure, which indicates risk of future bearish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 306.63 | Sell |
| 20-day SMA: | 310.61 | Sell |
| 50-day SMA: | 335.11 | Sell |
| 200-day SMA: | 346.35 | Sell |
| 8-day EMA: | 306 | Sell |
| 20-day EMA: | 312.85 | Sell |
| 50-day EMA: | 328.53 | Sell |
| 200-day EMA: | 331.32 | Sell |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.19 | Sell |
| Relative Strength Index (14 RSI): | 33.01 | Sell |
| Chaikin Money Flow: | -440580 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (304.5 - 316.98) | Sell |
| Bollinger Bands (100): | (324.98 - 379.92) | Sell |
United Therapeutics Technical Analysis
| Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 292.46 while UTHR 8-day simple moving average is 306.63, which is a Sell signal.
-
The stock price of UTHR is 292.46 while United Therapeutics 20-day SMA is 310.61, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 335.11 while UTHR share price is 292.46, making it a Sell technically.
-
UTHR stock price is 292.46 and United Therapeutics 200-day simple moving average is 346.35, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Sell
42
United Therapeutics (UTHR)
is a Sell
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a SellThe current United Therapeutics [UTHR] share price is $292.46. The Score for UTHR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
United Therapeutics Stock Info
Market Cap:
13.1B
Price in USD:
292.46
Share Volume:
579.5K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
230.39
Sell
42
United Therapeutics (UTHR)
is a Sell
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 292.46 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 292.46 while UTHR 8-day exponential moving average is 306.00, which is a Sell signal.
-
The stock price of UTHR is 292.46 while United Therapeutics 20-day EMA is 312.85, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 328.53 while UTHR share price is 292.46, making it a Sell technically.
-
UTHR stock price is 292.46 and United Therapeutics 200-day simple moving average is 331.32, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.65 per share, and an increase next year of $0.19 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -8.19, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 33.01, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (304.5 - 316.98), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (324.98 - 379.92), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.